PIAS/SUMO: new partners in transcriptional regulation
- PMID: 14685683
- PMCID: PMC11138616
- DOI: 10.1007/s00018-003-3129-1
PIAS/SUMO: new partners in transcriptional regulation
Abstract
Protein inhibitor of activated STATs (PIAS) proteins were initially identified as negative regulators of cytokine signalling that inhibit the activity of STAT-transcription factors. Evidence is accumulating that PIAS proteins function as transcriptional coregulators in various other important cellular pathways, including Wnt signalling, the p53 pathway and steroid hormone signalling. Most interestingly, recent work from several laboratories revealed that PIAS proteins act as E3-like ligases that stimulate the attachment of the ubiquitin-like SUMO modifier to target proteins acting in these pathways. Since in most cases the SUMO ligase activity and the transcriptional coregulator activity are functionally correlated, the PIAS/SUMO pathway appears to be an important mechanism of transcriptional regulation. In this review we will discuss some key findings that exemplify the role of PIAS proteins in the regulation of transcriptional processes and propose a model how the PIAS/ SUMO system may modulate transcriptional activities by mediating the assembly of coactivator or corepressor complexes within distinct subnuclear structures.
Similar articles
-
PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.Biochem Soc Trans. 2007 Dec;35(Pt 6):1405-8. doi: 10.1042/BST0351405. Biochem Soc Trans. 2007. PMID: 18031232 Review.
-
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2872-7. doi: 10.1073/pnas.052559499. Epub 2002 Feb 26. Proc Natl Acad Sci U S A. 2002. PMID: 11867732 Free PMC article.
-
PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.Mol Cell Biol. 2002 Jul;22(14):5222-34. doi: 10.1128/MCB.22.14.5222-5234.2002. Mol Cell Biol. 2002. PMID: 12077349 Free PMC article.
-
SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.J Biol Chem. 2003 Aug 8;278(32):30091-7. doi: 10.1074/jbc.M301344200. Epub 2003 May 22. J Biol Chem. 2003. PMID: 12764129
-
PIAS proteins: pleiotropic interactors associated with SUMO.Cell Mol Life Sci. 2009 Sep;66(18):3029-41. doi: 10.1007/s00018-009-0061-z. Epub 2009 Jun 13. Cell Mol Life Sci. 2009. PMID: 19526197 Free PMC article. Review.
Cited by
-
Transcriptome Profile and Gene Expression During Different Ovarian Maturation Stages of Macrobrachium rosenbergii (De Man, 1879).Trop Life Sci Res. 2024 Oct;35(3):77-108. doi: 10.21315/tlsr2024.35.3.4. Epub 2024 Oct 7. Trop Life Sci Res. 2024. PMID: 39464661 Free PMC article.
-
PIAS family in cancer: from basic mechanisms to clinical applications.Front Oncol. 2024 Mar 25;14:1376633. doi: 10.3389/fonc.2024.1376633. eCollection 2024. Front Oncol. 2024. PMID: 38590645 Free PMC article. Review.
-
Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy.Eur J Med Res. 2024 Mar 25;29(1):195. doi: 10.1186/s40001-024-01795-7. Eur J Med Res. 2024. PMID: 38528630 Free PMC article.
-
ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway.Exp Hematol Oncol. 2024 Jan 22;13(1):5. doi: 10.1186/s40164-024-00475-w. Exp Hematol Oncol. 2024. PMID: 38254216 Free PMC article.
-
ZMIZ1 Regulates Proliferation, Autophagy and Apoptosis of Colon Cancer Cells by Mediating Ubiquitin-Proteasome Degradation of SIRT1.Biochem Genet. 2024 Aug;62(4):3245-3259. doi: 10.1007/s10528-023-10573-9. Epub 2024 Jan 12. Biochem Genet. 2024. PMID: 38214831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
